Kindstar Globalgene Technology, Inc.
HKEX:9960.HK
1.22 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 967.26 | 1,386.591 | 930.673 | 891.391 | 832.791 | 706.202 |
| Cost of Revenue
| 516.131 | 783.536 | 444.903 | 430.41 | 380.577 | 327.806 |
| Gross Profit
| 451.129 | 603.055 | 485.77 | 460.981 | 452.214 | 378.396 |
| Gross Profit Ratio
| 0.466 | 0.435 | 0.522 | 0.517 | 0.543 | 0.536 |
| Reseach & Development Expenses
| 105.337 | 101.226 | 90.325 | 75.282 | 79.023 | 73.583 |
| General & Administrative Expenses
| 105.626 | 80.406 | 99.58 | 29.193 | 13.778 | 12.137 |
| Selling & Marketing Expenses
| 307.781 | 360.562 | 282.24 | 248.521 | 274.599 | 249.528 |
| SG&A
| 413.407 | 440.968 | 381.82 | 277.714 | 288.377 | 261.665 |
| Other Expenses
| -2.663 | -9.693 | -23.954 | 14.959 | 27.017 | -70.664 |
| Operating Expenses
| 493.6 | 532.501 | 448.191 | 367.955 | 394.417 | 358.931 |
| Operating Income
| -86.738 | 131.886 | -1,450.075 | -951.037 | -159.894 | 19.465 |
| Operating Income Ratio
| -0.09 | 0.095 | -1.558 | -1.067 | -0.192 | 0.028 |
| Total Other Income Expenses Net
| 130.06 | -48.57 | -3.913 | -11.315 | -8.711 | -78.88 |
| Income Before Tax
| 43.322 | 83.316 | -1,453.988 | -962.352 | -168.605 | -59.415 |
| Income Before Tax Ratio
| 0.045 | 0.06 | -1.562 | -1.08 | -0.202 | -0.084 |
| Income Tax Expense
| 6.875 | 5.832 | 0.246 | 7.768 | 0.977 | -5.066 |
| Net Income
| 41.286 | 75.457 | -1,454.234 | -970.12 | -169.582 | -52.674 |
| Net Income Ratio
| 0.043 | 0.054 | -1.563 | -1.088 | -0.204 | -0.075 |
| EPS
| 0.043 | 0.095 | -2.93 | -1.08 | -0.19 | -0.058 |
| EPS Diluted
| 0.043 | 0.092 | -2.93 | -1.07 | -0.19 | -0.058 |
| EBITDA
| 108.016 | 196.774 | -1,392.642 | -900.242 | -117.292 | -11.235 |
| EBITDA Ratio
| 0.112 | 0.142 | -1.496 | -1.01 | -0.141 | -0.016 |